| Name | Designation | Appointment Date | Status | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sujatha Tanniru
Appointed as Additional Director since July 2015 |
Additional Director | 22-Jul-2015 | Current | ||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Abdul Mukaram Mohammed
Appointed as Director since December 2023 |
Director | 30-Dec-2023 | Current | ||||||||||||||||||||||||||||
|
Vijay Bhaskar Bandla
Appointed as Managing Director since July 2011 |
Managing Director | 28-Jul-2011 | Current | ||||||||||||||||||||||||||||
|
Krutika Misra
Appointed as Director since September 2014 |
Director | 30-Sep-2014 | Current | ||||||||||||||||||||||||||||
People Timeline
Explore the timeline of key personnel in Inavir Pharmatech Private Limited's leadership journey.
Loading...
Contact Details
- Address H.No: 7-1-643 & 643/1, Bhanu Enclave, Flat No.119, Sundar Nagar,Besides Esi Hospital, S.R N, Agar,, Hyderabad Telangana, 500038, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 500038
- Country India
- Website inavirpharma.com
Frequently Asked Questions
How can I contact Inavir Pharmatech Private Limited?
You can contact Inavir Pharmatech Private Limited through their registered address at H.No: 7-1-643 & 643/1, Bhanu Enclave, Flat No.119, Sundar Nagar,Besides Esi Hospital, S.R N, Agar,, Hyderabad Telangana, 500038, India, or via their website at inavirpharma.com. Social media links are also provided where applicable.
Who are the current directors of Inavir Pharmatech Private Limited?
The current directors of Inavir Pharmatech Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- SUJATHA TANNIRU
- Abdul Mukaram Mohammed
- VIJAY BHASKAR BANDLA
- KRUTIKA MISRA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.